Icahn School Of Medicine At Mount Sinai

Insider Reports History

Entity
Individual
Location
1 Gustave L. Levy Place, New York, NY
Signature
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI By: /s/ Stephen Harvey, Name: Stephen Harvey, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Icahn School Of Medicine At Mount Sinai:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GeneDx Holdings Corp. 10%+ Owner Class A Common Stock 123M $399M $3.24 Jan 31, 2023 Direct
Renalytix plc 10%+ Owner Ordinary Shares 19.3M $4.83M $0.25 Apr 24, 2024 Direct
Renalytix plc 10%+ Owner American Depositary Shares 2.33M Apr 24, 2024 Direct

Insider Reports Filed by Icahn School Of Medicine At Mount Sinai

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNLX Renalytix plc Apr 24, 2024 1 $2.34M 4 Apr 26, 2024 10%+ Owner
RNLX Renalytix plc Jul 1, 2023 0 $0 3 Jul 3, 2023 10%+ Owner
WGS GeneDx Holdings Corp. Jan 31, 2023 1 $10M 4 Feb 2, 2023 10%+ Owner
WGSWW Sema4 Holdings Corp. Apr 29, 2022 1 $25M 4 May 5, 2022 10%+ Owner
WGSWW Sema4 Holdings Corp. Jul 22, 2021 0 $0 3 Oct 7, 2021 10%+ Owner